<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>0124-8146</journal-id>
<journal-title><![CDATA[Investigaciones Andina]]></journal-title>
<abbrev-journal-title><![CDATA[Investig. andina]]></abbrev-journal-title>
<issn>0124-8146</issn>
<publisher>
<publisher-name><![CDATA[Fundación Universitaria del Área Andina - FUNANDI]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S0124-81462019000100167</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[EVALUACIÓN DE LA EFICACIA DE DOS TERAPIAS ESTROGÉNICAS LOCALES MÁS UN LUBRICANTE VAGINAL, PARA EL CONTROL DE LOS SÍNTOMAS DEL SÍNDROME GENITOURINARIO DE LA MENOPAUSIA]]></article-title>
<article-title xml:lang="en"><![CDATA[EVALUATION OF THE EFFECTIVENESS OF THE COMBINATION OF TWO LOCAL ESTROGENIC THERAPIES WITH A VAGINAL LUBRICANT, FOR THE SYMPTOMS CONTROL OF GENITOURINARY SYNDROME OF MENOPAUSE]]></article-title>
<article-title xml:lang="pt"><![CDATA[AVALIAÇÃO DA EFICÁCIA DA COMBINAÇÃO DE DUAS TERÁPIAS COM ESTROGÊNIO LOCAL COM UM LUBRIFICANTE VAGINAL, PARA O CONTROLE DOS SINTOMAS DA SÍNDROME GENITURINÁRIA DA MENOPAUSA]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Espitia De La Hoz]]></surname>
<given-names><![CDATA[Franklin José]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Orozco Gallego]]></surname>
<given-names><![CDATA[Hoover]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Universidad Militar Nueva Granada  ]]></institution>
<addr-line><![CDATA[Armenia Quindío]]></addr-line>
<country>Colombia</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,Universidad Tecnológica De Pereira - UTP  ]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
<country>Colombia</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>06</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>06</month>
<year>2019</year>
</pub-date>
<volume>21</volume>
<numero>38</numero>
<fpage>167</fpage>
<lpage>183</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.org.co/scielo.php?script=sci_arttext&amp;pid=S0124-81462019000100167&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.co/scielo.php?script=sci_abstract&amp;pid=S0124-81462019000100167&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.co/scielo.php?script=sci_pdf&amp;pid=S0124-81462019000100167&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[Resumen  Objetivo: Evaluar la eficacia de dos terapias estrogénicas locales más un lubricante vaginal (K-Y gel), para el control de los síntomas del síndrome genitourinario de la menopausia.  Materiales y métodos: Ensayo clínico, aleatorizado, prospectivo y controlado, no enmascarado. Se incluyeron 57 mujeres posmenopáusicas atendidas en la consulta de climaterio, entre julio de 2014 y julio de 2016. Se asignaron dos grupos aleatorizados: grupo A (30 mujeres recibieron 0.625 mg intravaginales de estrógenos equinos conjugados dos veces a la semana), y grupo B (27 mujeres recibieron 0,5 mg intravaginales de estriol dos veces a la semana) durante seis meses. Ambos grupos recibieron, adicional a la terapia hormonal, 5 gramos intravaginales del lubricante cada 6 horas. A todas las mujeres, para evaluar el estatus hormonal, antes del inicio y a los seis meses, se les determinó el índice de maduración vaginal, y mensualmente se les evaluaba la mejoría de la sintomatología del síndrome genitourinario de la menopausia, además de calcularles el índice de salud vaginal.  Resultados: La edad promedio del grupo fue de 58,03±4,85 años. Se observó una significativa disminución en los síntomas en el grupo B, comparado con el grupo A (p&lt;0,001), al mes (p&lt;0,001) y a los 6 meses de seguimiento (p=0,018). El tiempo para lograr una mejor puntuación en el índice de salud vaginal, fue significativamente menor en el grupo B. Al final de la investigación, la evaluación de los cambios en el índice de maduración vaginal, mostró un aumento en las células superficiales e intermedias, en el grupo B, superior al grupo A, mientras se reportó mayor disminución en el porcentaje de células parabasales del grupo B. Las mujeres del grupo A mostraron una reducción en la sintomatología, al final del estudio, del 72% frente al 87% del grupo B.  Conclusiones: El uso de la terapia estrogénica local, en el síndrome genitourinario de la menopausia, a los seis meses de seguimiento, pone de manifiesto una mejoría significativa de los síntomas. El uso de estriol más lubricante, se asoció con mejores resultados y menores efectos adversos, en comparación con los estrógenos equinos conjugados más lubricante.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[Abstract  Objective. To evaluate the efficacy of the combination of two local estrogenic therapies with a vaginal lubricant (K-Y gel), to control the symptoms of the severe atrophic vulvovaginitis.  Materials and methods. Prospective, controlled and randomized study. Fifty-seven postmenopausal women treated by the author in the climacteric consultation, between July 2014 and July 2016 were included. Two groups were established, 30 women received twice a week 0.625 mg intrava-ginal conjugated equine estrogens (group A), and 27 Women received twice a week during six months Estriol at doses of 0.5 mg intravaginal (group B). Both groups received, in addition to the hormonal therapy, 5 grams of intravaginal lubricant every 6 hours. In order to evaluate the hormonal status of all women, before starting and six months later, their vaginal maturity index was determined, simultaneously, the vaginal health index was calculated monthly in each control.  Results. The women of group A showed a symptoms reduction, at the end of the study, of 72% compared to 87% of group B. None of the women presented complications related to therapy.  Conclusions. The use of local estrogen therapy, in severe atrophic vulvovaginitis, is a well-tolerated measure; after six months of monitoring, a significant improvement of the symptoms and the vaginal health index is evidenced. The use of estriol with lubricant was associated with better results and less adverse effects, compared to conjugated equine estrogens and lubricant; however, the rates of sexual satisfaction were similar.]]></p></abstract>
<abstract abstract-type="short" xml:lang="pt"><p><![CDATA[Resumo  Objetivo. Avaliar a eficácia da combinação de duas terapias com estrogênio local com um lubrificante vaginal (K-Y gel), para o controle dos sintomas da vulvovaginite atrófica grave.  Materiais e métodos. Estudo prospectivo, controlado e randomizado. Foram incluídas 57 mulheres na pós-menopausa que frequentam consulta de clima-tério do autor, entre julho de 2014 e julho de 2016. Dois grupos foram estabelecidos, 30 mulheres receberam 0,625 mg de estrogénios equinos conjugados, duas vezes por semana por via intravaginal (grupo A), e 27 mulheres receberam estriol em doses de 0,5 mg intravaginalmente duas vezes por semana durante seis meses (grupo B). Ambos os grupos receberam, além da terapia hormonal, 5 gramas de lubrificante intravaginal a cada 6 horas. A fim de avaliar o estado hormonal, antes do início e aos seis meses, determinou-se o índice de maturidade vaginal, para todas as mulheres, calculando-se simultaneamente o índice de saúde vaginal, que foi continuado mensalmente em cada controle.  Resultados. As mulheres do grupo A apresentaram redução da sintomatologia, ao final do estudo, de 72% contra 87% do grupo B. Nenhuma das mulheres apresentou complicações relacionadas à terapia.  Conclusões. O uso de terapia de estrogênio local, na vulvovaginite atrófica grave, é uma medida bem tolerada; aos seis meses de acompanhamento, é evidente uma melhora significativa dos sintomas e do índice de saúde vaginal. O uso de estriol com lubrificante, foi associado com melhores resultados e menos efeitos adversos, comparado aos estrogênios e lubrificantes equinos conjugados; no entanto, as taxas de satisfação sexual foram semelhantes.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[Atrofia]]></kwd>
<kwd lng="es"><![CDATA[Estrógenos]]></kwd>
<kwd lng="es"><![CDATA[Menopausia]]></kwd>
<kwd lng="es"><![CDATA[Lubricantes]]></kwd>
<kwd lng="es"><![CDATA[Vulvovaginitis]]></kwd>
<kwd lng="es"><![CDATA[Dispareunia]]></kwd>
<kwd lng="en"><![CDATA[Climacteric]]></kwd>
<kwd lng="en"><![CDATA[Lubricant]]></kwd>
<kwd lng="en"><![CDATA[Urogenital system]]></kwd>
<kwd lng="en"><![CDATA[Hormone replacement therapy]]></kwd>
<kwd lng="en"><![CDATA[Vulvovaginitis]]></kwd>
<kwd lng="pt"><![CDATA[climatério]]></kwd>
<kwd lng="pt"><![CDATA[lubrificante]]></kwd>
<kwd lng="pt"><![CDATA[sistema urogenital]]></kwd>
<kwd lng="pt"><![CDATA[terapia de reposição hormonal]]></kwd>
<kwd lng="pt"><![CDATA[vulvovaginite]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lovatsis]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Drutz]]></surname>
<given-names><![CDATA[HP]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The role of estrogen in female urinary incontinence and urogenital aging: a review]]></article-title>
<source><![CDATA[Ostomy Wound Manage]]></source>
<year>1998</year>
<volume>44</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>48-53</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Espitia]]></surname>
<given-names><![CDATA[De La Hoz]]></given-names>
</name>
<name>
<surname><![CDATA[FJ]]></surname>
<given-names><![CDATA[Orozco]]></given-names>
</name>
<name>
<surname><![CDATA[Gallego]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Abordaje diagnóstico y terapéutico del síndrome genitourinario en la menopausia]]></article-title>
<source><![CDATA[actualización]]></source>
<year>2017</year>
<volume>11</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>67-84</page-range></nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<collab>North American Menopause Society</collab>
<article-title xml:lang=""><![CDATA[The role of local vaginal estrogen for treatment of vaginal atrophy in postmenopausal women: 2007 position statement of The North American Menopause Society]]></article-title>
<source><![CDATA[Menopause]]></source>
<year>2007</year>
<volume>14</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>355-69</page-range></nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Cardozo]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Bachmann]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[McClish]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Fonda]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Birgerson]]></surname>
<given-names><![CDATA[L.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Meta-analysis of estrogen therapy in the management of urogenital atrophy in postmenopausal women: second report of the Hormones and Urogenital Therapy Committee]]></article-title>
<source><![CDATA[Obstet Gynecol]]></source>
<year>1998</year>
<volume>92</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>722-7</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Calleja-Agius]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Brincat]]></surname>
<given-names><![CDATA[MP]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Urogenital atrophy]]></article-title>
<source><![CDATA[Climacteric]]></source>
<year>2009</year>
<volume>12</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>279-85</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Versi]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Cardozo]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Brincat]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Cooper]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Montgomery]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Studd]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Correlation of urethral physiology and skin collagen in postmenopausal women]]></article-title>
<source><![CDATA[Br J Obstet Gynaecol]]></source>
<year>1988</year>
<volume>95</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>147-52</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Nachtigall]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Nachtigall]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Goren]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Loewenstein]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<source><![CDATA[Update on vaginal atrophy. Menopause Manag]]></source>
<year>2005</year>
<page-range>17-9</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bachmann]]></surname>
<given-names><![CDATA[GA]]></given-names>
</name>
<name>
<surname><![CDATA[Nevadunsky]]></surname>
<given-names><![CDATA[NS]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Diagnosis and treatment of atrophic vaginitis]]></article-title>
<source><![CDATA[Am Fam Physician]]></source>
<year>2000</year>
<volume>15</volume>
<numero>10</numero>
<issue>10</issue>
<page-range>3090-6</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Castelo-Branco]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Cancelo]]></surname>
<given-names><![CDATA[MJ]]></given-names>
</name>
<name>
<surname><![CDATA[Villero]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Nohales]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Juliá]]></surname>
<given-names><![CDATA[MD]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Management of post-menopausal vaginal atrophy and atrophic vaginitis]]></article-title>
<source><![CDATA[Maturitas]]></source>
<year>2005</year>
<volume>15;52</volume>
<numero>^s1</numero>
<issue>^s1</issue>
<supplement>1</supplement>
<page-range>S46-52</page-range></nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Krychman]]></surname>
<given-names><![CDATA[ML]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Vaginal estrogens for the treatment of dyspareunia]]></article-title>
<source><![CDATA[J Sex Med]]></source>
<year>2011</year>
<volume>8</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>666-74</page-range></nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="journal">
<collab>North American Menopause Society</collab>
<article-title xml:lang=""><![CDATA[Estrogen and progestogen use in post-menopausal women: 2010 position statement of The North American Menopause Society]]></article-title>
<source><![CDATA[Menopause]]></source>
<year>2010</year>
<volume>17</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>242-55</page-range></nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Long]]></surname>
<given-names><![CDATA[CY]]></given-names>
</name>
<name>
<surname><![CDATA[Liu]]></surname>
<given-names><![CDATA[CM]]></given-names>
</name>
<name>
<surname><![CDATA[Hsu]]></surname>
<given-names><![CDATA[SC]]></given-names>
</name>
<name>
<surname><![CDATA[Wu]]></surname>
<given-names><![CDATA[CH]]></given-names>
</name>
<name>
<surname><![CDATA[Wang]]></surname>
<given-names><![CDATA[CL]]></given-names>
</name>
<name>
<surname><![CDATA[Tsai]]></surname>
<given-names><![CDATA[EM]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[A randomized comparative study of the effects of oral and topical estrogen therapy on the vaginal vascularization and sexual function in hysterectomized postmenopausal women.]]></article-title>
<source><![CDATA[Menopause]]></source>
<year>2006</year>
<volume>13</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>737-43</page-range></nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Simon]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Nachtigall]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Gut]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Lang]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Archer]]></surname>
<given-names><![CDATA[DF]]></given-names>
</name>
<name>
<surname><![CDATA[Utian]]></surname>
<given-names><![CDATA[W]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Effective treatment of vaginal atrophy with an ultra-low-dose estradiol vaginal tablet]]></article-title>
<source><![CDATA[Obstet Gynecol]]></source>
<year>2008</year>
<volume>112</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>1053-60</page-range></nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Nappi]]></surname>
<given-names><![CDATA[RE]]></given-names>
</name>
<name>
<surname><![CDATA[Davis]]></surname>
<given-names><![CDATA[SR]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The use of hormone therapy for the maintenance of urogynecological and sexual health post WHI]]></article-title>
<source><![CDATA[Climacteric]]></source>
<year>2012</year>
<volume>15</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>267-74</page-range></nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lee]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Kim]]></surname>
<given-names><![CDATA[TH]]></given-names>
</name>
<name>
<surname><![CDATA[Lee]]></surname>
<given-names><![CDATA[HH]]></given-names>
</name>
<name>
<surname><![CDATA[Kim]]></surname>
<given-names><![CDATA[YS]]></given-names>
</name>
<name>
<surname><![CDATA[Enkh-bold]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Lee]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Park]]></surname>
<given-names><![CDATA[YJ]]></given-names>
</name>
<name>
<surname><![CDATA[Song]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Therapeutic Approaches to Atrophic Vaginitis in Postmenopausal Women: A Systematic Review with a Network Meta-analysis of Randomized Controlled Trials]]></article-title>
<source><![CDATA[Menopausal Med]]></source>
<year>2018</year>
<volume>24</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>1-10</page-range></nlm-citation>
</ref>
<ref id="B16">
<label>16</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Cano]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Estévez]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Usandizaga]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Gallo]]></surname>
<given-names><![CDATA[JL]]></given-names>
</name>
<name>
<surname><![CDATA[Guinot]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Delgado]]></surname>
<given-names><![CDATA[JL]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The therapeutic effect of a new ultra low concentration estriol gel formulation (0.005% estriol vaginal gel) on symptoms and signs of postmenopausal vaginal atrophy: results from a pivotal phase III study]]></article-title>
<source><![CDATA[Menopause]]></source>
<year>2012</year>
<volume>19</volume>
<numero>10</numero>
<issue>10</issue>
<page-range>1130-9</page-range></nlm-citation>
</ref>
<ref id="B17">
<label>17</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hickey]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Saunders]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Partridge]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Santoro]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Joffe]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Stearns]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Practical clinical guidelines for assessing and managing menopausal symptoms after breast cancer]]></article-title>
<source><![CDATA[Ann Oncol]]></source>
<year>2008</year>
<volume>19</volume>
<numero>10</numero>
<issue>10</issue>
<page-range>1669-80</page-range></nlm-citation>
</ref>
<ref id="B18">
<label>18</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Espitia De La Hoz]]></surname>
<given-names><![CDATA[FJ]]></given-names>
</name>
</person-group>
<source><![CDATA[Mi primer año en La Crónica]]></source>
<year>2016</year>
<volume>5</volume>
<numero>3</numero>
<edition>Primera</edition>
<issue>3</issue>
<page-range>71-2</page-range><publisher-loc><![CDATA[Bogotá ]]></publisher-loc>
<publisher-name><![CDATA[Editorial Bolívar]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B19">
<label>19</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Espitia, De La Hoz]]></surname>
<given-names><![CDATA[FJ]]></given-names>
</name>
</person-group>
<source><![CDATA[Sexo Ilimitado / El vuelo hacia una sexualidad más placentera]]></source>
<year>2015</year>
<volume>2</volume>
<numero>15</numero>
<edition>Primera</edition>
<issue>15</issue>
<page-range>181-5</page-range><publisher-loc><![CDATA[Bogotá ]]></publisher-loc>
<publisher-name><![CDATA[Editorial Bolívar]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B20">
<label>20</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Palacios]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Cancelo]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Castelo-Branco]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[González]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Recomendaciones de la Sociedad Española de Ginecología y Obstetricia sobre la prevención y el tratamiento de la atrofia vaginal]]></article-title>
<source><![CDATA[Prog Obstet Ginecol]]></source>
<year>2012</year>
<volume>55</volume>
<numero>8</numero>
<issue>8</issue>
<page-range>408-15</page-range></nlm-citation>
</ref>
<ref id="B21">
<label>21</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Rees]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Pérez-López]]></surname>
<given-names><![CDATA[FR]]></given-names>
</name>
<name>
<surname><![CDATA[Ceasu]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Depypere]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Erel]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Lambrinoudaki]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[EMAS clinical guide: low-dose vaginal estrogens for postmenopausal vaginal atrophy]]></article-title>
<source><![CDATA[Maturitas]]></source>
<year>2012</year>
<volume>73</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>171-4</page-range></nlm-citation>
</ref>
<ref id="B22">
<label>22</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gandhi]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Chen]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Dagur]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Suh]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Smith]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Cali]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Khan]]></surname>
<given-names><![CDATA[SA.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Genitourinary syndrome of menopause: an overview of clinical manifestations, pathophysiology, etiology, evaluation, and management]]></article-title>
<source><![CDATA[Am J Obstet Gynecol]]></source>
<year>2016</year>
<volume>215</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>704-11</page-range></nlm-citation>
</ref>
<ref id="B23">
<label>23</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Espitia-De La Hoz]]></surname>
<given-names><![CDATA[FJ]]></given-names>
</name>
<name>
<surname><![CDATA[Orozco-Gallego]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Estriol vs estrógenos conjugados de origen equino en el tratamiento del síndrome genitourinario de la menopausia]]></article-title>
<source><![CDATA[Ginecol Obstet Mex]]></source>
<year>2018</year>
<volume>86</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>117-26</page-range></nlm-citation>
</ref>
<ref id="B24">
<label>24</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Shifren]]></surname>
<given-names><![CDATA[JL]]></given-names>
</name>
<name>
<surname><![CDATA[Gass]]></surname>
<given-names><![CDATA[ML]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[NAMS Recommendations for Clinical Care of Midlife Women Working Group. The North American Menopause Society recommendations for clinical care of midlife women]]></article-title>
<source><![CDATA[Menopause]]></source>
<year>2014</year>
<volume>21</volume>
<numero>10</numero>
<issue>10</issue>
<page-range>1038-62</page-range></nlm-citation>
</ref>
<ref id="B25">
<label>25</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Sturdee]]></surname>
<given-names><![CDATA[DW]]></given-names>
</name>
<name>
<surname><![CDATA[Panay]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[International Menopause Society Writing Group. Recommendations for the management of postmenopausal vaginal atrophy]]></article-title>
<source><![CDATA[Climacteric]]></source>
<year>2010</year>
<volume>13</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>509-22</page-range></nlm-citation>
</ref>
<ref id="B26">
<label>26</label><nlm-citation citation-type="journal">
<collab>North American Menopause Society</collab>
<article-title xml:lang=""><![CDATA[Management of symptomatic vulvovaginal atrophy: 2013 position statement of The North American Menopause Society]]></article-title>
<source><![CDATA[Menopause]]></source>
<year>2013</year>
<volume>20</volume>
<numero>9</numero>
<issue>9</issue>
<page-range>888-902</page-range></nlm-citation>
</ref>
<ref id="B27">
<label>27</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Santen]]></surname>
<given-names><![CDATA[RJ]]></given-names>
</name>
<name>
<surname><![CDATA[Allred]]></surname>
<given-names><![CDATA[DC]]></given-names>
</name>
<name>
<surname><![CDATA[Ardoin]]></surname>
<given-names><![CDATA[SP]]></given-names>
</name>
<name>
<surname><![CDATA[Archer]]></surname>
<given-names><![CDATA[DF]]></given-names>
</name>
<name>
<surname><![CDATA[Boyd]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Braunstein]]></surname>
<given-names><![CDATA[GD]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Postmenopausal hormone therapy: an Endocrine Society scientific statement]]></article-title>
<source><![CDATA[J Clin Endocrinol Metab]]></source>
<year>2010</year>
<volume>95</volume>
<numero>^s7</numero>
<issue>^s7</issue>
<supplement>7</supplement>
<page-range>s1-s66</page-range></nlm-citation>
</ref>
<ref id="B28">
<label>28</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[De Villiers]]></surname>
<given-names><![CDATA[TJ]]></given-names>
</name>
<name>
<surname><![CDATA[Pines]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Panay]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Gambacciani]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Archer]]></surname>
<given-names><![CDATA[DF]]></given-names>
</name>
<name>
<surname><![CDATA[Baber]]></surname>
<given-names><![CDATA[RJ]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Updated 2013 International Menopause Society recommendations on menopausal hormone therapy and preventive strategies for midlife health]]></article-title>
<source><![CDATA[Climacteric]]></source>
<year>2013</year>
<volume>16</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>316-37</page-range></nlm-citation>
</ref>
<ref id="B29">
<label>29</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Weinberger]]></surname>
<given-names><![CDATA[JM]]></given-names>
</name>
<name>
<surname><![CDATA[Houman]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Caron A]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Anger]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Female Sexual Dysfunction: A Systematic Review of Outcomes Across Various Treatment Modalities]]></article-title>
<source><![CDATA[Sex Med Rev]]></source>
<year>2018</year>
<page-range>1-28</page-range></nlm-citation>
</ref>
<ref id="B30">
<label>30</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Van der Linden]]></surname>
<given-names><![CDATA[MC]]></given-names>
</name>
<name>
<surname><![CDATA[Gerretsen]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Brandhorst]]></surname>
<given-names><![CDATA[MS]]></given-names>
</name>
<name>
<surname><![CDATA[Ooms]]></surname>
<given-names><![CDATA[EC]]></given-names>
</name>
<name>
<surname><![CDATA[Kremer]]></surname>
<given-names><![CDATA[CM]]></given-names>
</name>
<name>
<surname><![CDATA[Doesburg]]></surname>
<given-names><![CDATA[WH]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The effect of estriol on the cytology of urethra and vagina in post-menopausal women with genitourinary symptoms]]></article-title>
<source><![CDATA[Eur J Obstet Gynecol Reprod Biol]]></source>
<year>1993</year>
<volume>51</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>29-33</page-range></nlm-citation>
</ref>
<ref id="B31">
<label>31</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Dessole]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Rubattu]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Ambrosini]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Gallo]]></surname>
<given-names><![CDATA[O]]></given-names>
</name>
<name>
<surname><![CDATA[Capobianco]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Cherchi]]></surname>
<given-names><![CDATA[PL]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Efficacy of low-dose intravaginal estriol on urogenital aging in postmenopausal women]]></article-title>
<source><![CDATA[Menopause]]></source>
<year>2004</year>
<volume>11</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>49-56</page-range></nlm-citation>
</ref>
<ref id="B32">
<label>32</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Espitia, De La Hoz]]></surname>
<given-names><![CDATA[FJ]]></given-names>
</name>
<name>
<surname><![CDATA[Orozco, Gallego]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Echeverri, Ocampo]]></surname>
<given-names><![CDATA[LM]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Terapia hormonal y no hormonal en la vaginitis atrófica posmenopáusica: cura y satisfacción a mediano y a largo plazo de los síntomas]]></article-title>
<source><![CDATA[Rev. Col. de Menopausia]]></source>
<year>2016</year>
<volume>22</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>8-17</page-range></nlm-citation>
</ref>
<ref id="B33">
<label>33</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Nappi]]></surname>
<given-names><![CDATA[RE]]></given-names>
</name>
<name>
<surname><![CDATA[Biglia]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Cagnacci]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Di Carlo]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Luisi]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Paoletti]]></surname>
<given-names><![CDATA[AM]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Diagnosis and management of symptoms associated with vulvovaginal atrophy: expert opinion on behalf of the Italian VVA study group]]></article-title>
<source><![CDATA[Gynecol Endocrinol]]></source>
<year>2016</year>
<volume>32</volume>
<numero>8</numero>
<issue>8</issue>
<page-range>602-6</page-range></nlm-citation>
</ref>
<ref id="B34">
<label>34</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Simon]]></surname>
<given-names><![CDATA[JA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Identifying and treating sexual dysfunction in postmenopausal women: the role of estrogen]]></article-title>
<source><![CDATA[J Womens Health (Larchmt)]]></source>
<year>2011</year>
<volume>20</volume>
<numero>10</numero>
<issue>10</issue>
<page-range>1453-65</page-range></nlm-citation>
</ref>
<ref id="B35">
<label>35</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lethaby]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Ayeleke]]></surname>
<given-names><![CDATA[RO]]></given-names>
</name>
<name>
<surname><![CDATA[Roberts]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Local oestrogen for vaginal atrophy in post-menopausal women]]></article-title>
<source><![CDATA[Cochrane Database Syst Rev]]></source>
<year>2016</year>
<volume>31</volume>
<numero>8</numero>
<issue>8</issue>
<page-range>CD001500</page-range></nlm-citation>
</ref>
<ref id="B36">
<label>36</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Chism]]></surname>
<given-names><![CDATA[LA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Overcoming resistance and barriers to the use of local estrogen therapy for the treatment of vaginal atrophy]]></article-title>
<source><![CDATA[Int J Womens Health]]></source>
<year>2012</year>
<volume>4</volume>
<page-range>551-7</page-range></nlm-citation>
</ref>
<ref id="B37">
<label>37</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Rahn]]></surname>
<given-names><![CDATA[DD]]></given-names>
</name>
<name>
<surname><![CDATA[Carberry]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Sanses]]></surname>
<given-names><![CDATA[TV]]></given-names>
</name>
<name>
<surname><![CDATA[Mamik]]></surname>
<given-names><![CDATA[MM]]></given-names>
</name>
<name>
<surname><![CDATA[Ward]]></surname>
<given-names><![CDATA[RM]]></given-names>
</name>
<name>
<surname><![CDATA[Meriwether]]></surname>
<given-names><![CDATA[KV]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Vaginal estrogen for genitourinary syndrome of menopause: a systematic review]]></article-title>
<source><![CDATA[Obstet Gynecol]]></source>
<year>2014</year>
<volume>124</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>1147-56</page-range></nlm-citation>
</ref>
<ref id="B38">
<label>38</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Nappi]]></surname>
<given-names><![CDATA[RE]]></given-names>
</name>
<name>
<surname><![CDATA[Kokot-Kierepa]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Women's voices in the menopause: results from an international survey on vaginal atrophy]]></article-title>
<source><![CDATA[Maturitas]]></source>
<year>2010</year>
<volume>67</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>233-8</page-range></nlm-citation>
</ref>
<ref id="B39">
<label>39</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Labrie]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Archer]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Bouchard]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Fortier]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Cusan]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Gomez]]></surname>
<given-names><![CDATA[JL]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Intra-vaginal dehydroepiandrosterone (Prasterone), a physiological and highly efficient treatment of vaginal atrophy]]></article-title>
<source><![CDATA[Menopause]]></source>
<year>2009</year>
<volume>16</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>907-22</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
